Danforth Health's Strategic Acquisition of Asymmetry Group
Danforth Health, a leader in life science innovation, has recently announced its acquisition of Asymmetry Group, a move designed to enhance its support for scientific advancements aimed at benefitting patients.
Growing Expertise in Commercial Strategy
This acquisition introduces a team of 30 seasoned professionals who specialize in corporate advisory, commercial strategy, launch planning, and execution. The partnership will bolster the capabilities of Danforth Health's Commercial & Marketing practices, providing clients with access to in-depth expertise and strategic support.
Leadership of Asymmetry Group
Greg Lief, the founder and Managing Director of Asymmetry Group, along with Managing Director Yakir Siegal, will continue to spearhead their team. Their extensive experience in helping companies successfully launch products will now benefit a wider range of clients under the Danforth Health umbrella.
Enhancing the Path to Market
Chris Connors, CEO of Danforth Health, shared insights about the significance of this acquisition. He remarked, "Advancing a therapy from development to market requires not only scientific and regulatory achievement but also early, strategic alignment around commercial goals." The expertise of Asymmetry Group will empower clients to navigate critical launch phases seamlessly.
Comprehensive Support for Life Science Leaders
According to Greg Lief, joining Danforth Health presents an opportunity to deliver increased value to healthcare innovators. This integrated model aligns commercialization strategy with a full spectrum of development, regulatory, financial, and communication expertise, ensuring that life science leaders can achieve impactful innovation.
A Reputation for Building Life Science Organizations
Founded in 2017, Asymmetry Group has earned a solid reputation for aiding both emerging and established life sciences companies in launching and scaling successfully. Their team's extensive experience spans corporate and asset commercialization strategies, innovative product launches, and organizational capability development, supporting clients as they tackle the intricacies of market entry and expansion.
Advancing the Danforth Health Strategic Vision
This latest move is part of Danforth Health's overarching strategy to create an integrated platform of specialized affiliates. The firm partners with industry leaders including Danforth Advisors, Advyzom, Argot Partners, Benchworks, Elite BioPharma Consulting, PharmaDirections, and VPMR—all committed to empowering life science innovation.
About Asymmetry Group
Asymmetry Group is dedicated to facilitating transformative impact within the healthcare industry. They excel by collaborating with top-tier organizations at the forefront of healthcare innovation, connecting strategic and operational insights to commercialize innovation effectively. Their expertise includes portfolio and product strategy as well as supporting new product launches.
About Danforth Health
Danforth Health serves as a comprehensive platform designed to propel life science innovation forward. By integrating expert resources across finance, regulatory, clinical, and marketing domains, Danforth Health offers customized, cross-functional support tailored to companies at any stage. This flexible model enables health organizations to accelerate their path from concept to patient delivery.
Contact:
Felicia Krupps
Danforth Health
fkrupps@danforthadvisors.com
Frequently Asked Questions
What is the significance of Danforth Health acquiring Asymmetry Group?
The acquisition strengthens Danforth Health’s capabilities in commercial strategy, enhancing support for clients throughout the product launch process.
Who are the leaders of Asymmetry Group?
Greg Lief and Yakir Siegal will continue to lead Asymmetry Group as it becomes part of Danforth Health.
What types of support does Danforth Health provide?
Danforth Health offers tailored support in areas like finance, regulatory affairs, clinical research, and marketing to life science companies.
How does this acquisition benefit clients?
Clients will now have access to a broader range of integrated services, allowing for enhanced market entry strategies and operational support.
When was Asymmetry Group founded?
Asymmetry Group was established in 2017 and has built a strong reputation in the life sciences sector since then.
